0001752724-23-020322.txt : 20230208
0001752724-23-020322.hdr.sgml : 20230208
20230208105135
ACCESSION NUMBER: 0001752724-23-020322
CONFORMED SUBMISSION TYPE: N-CEN
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20221130
FILED AS OF DATE: 20230208
DATE AS OF CHANGE: 20230208
EFFECTIVENESS DATE: 20230208
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAINSTAY FUNDS TRUST
CENTRAL INDEX KEY: 0001469192
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
FILING VALUES:
FORM TYPE: N-CEN
SEC ACT: 1940 Act
SEC FILE NUMBER: 811-22321
FILM NUMBER: 23597618
BUSINESS ADDRESS:
STREET 1: 51 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 212 576 7000
MAIL ADDRESS:
STREET 1: 51 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10010
0001469192
S000045768
MainStay Cushing MLP Premier Fund
C000142690
Class A
CSHAX
C000142691
Class C
CSHCX
C000142692
Class I
CSHZX
C000142693
Investor Class
CSHNX
N-CEN
1
primary_doc.xml
X0404
N-CEN
LIVE
0001469192
XXXXXXXX
811-22321
false
false
false
N-1A
S000045768
C000142690
C000142692
C000142693
C000142691
MAINSTAY FUNDS TRUST
811-22321
0001469192
549300SQRLBSUG7RD002
51 MADISON AVE
New York
10010
US-NY
US
212-576-7000
JPMorgan Chase Bank, N.A.
4 Chase Metrotech Center
Brooklyn
11245
718-242-0609
Records relating to its functions as custodian, sub-administrator and accounting agent
N
N
N-1A
33
Y
Alan R. Latshaw
000000000
N
Karen Hammond
000000000
N
Jacques P. Perold
000000000
N
Susan B. Kerley
000000000
N
David H. Chow
001401207
N
Richard S. Trutanic
000000000
N
Kevin M. Gleason
000000000
30 Hudson Street
Jersey City
07302
XXXXXX
Y
N
N
N
N
N
NYLIFE Distributors LLC
8-46655
000035350
00000000000000000000
Y
N
KPMG LLP
185
5493003PVCIGA21K0K42
N
N
N
N
N
N
MainStay Cushing MLP Premier Fund
S000045768
549300ESFNCM867SRU33
N
6
0
0
N/A
Y
N
N
N
N/A
0.00000000
0.00000000
Rule 18f-4 (17 CFR 270.18f-4)
Rule 32a-4 (17 CFR 270.32a-4)
Rule 22d-1 (17 CFR 270.22d-1)
Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4))
Rule 15a-4 (17 CFR 270.15a-4)
Y
N
N
N
New York Life Investment Management LLC
801-57396
000109591
IGJ1X7QLRC5K7CY9GE11
N
Cushing Asset Management LP
801-63255
000131517
549300J4XZOND2340P82
N
N
NYLIM Service Company LLC
084-05844
00000000000000000000
Y
N
DST Asset Manager Solutions, Inc.
84-00896
00000000000000000000
N
Y
N
ICE Data Pricing & Reference Data, LLC
5493000NQ9LYLDBCTL34
LEI Number
N
N
JPMorgan Chase Bank, N.A.
7H6GLXDRUGQFU57RNE97
N
N
Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
Royal Bank of Canada
ES7IP3U3RHIGC71XBU11
CA
N
Y
Foreign custodian - rule 17f-5 (17 CFR 270.17f-5)
N
DST Asset Manager Solutions, Inc.
84-00896
SEC File Number
N
N
NYLIM Service Company LLC
084-05844
SEC File Number
Y
N
N
New York Life Investment Management LLC
IGJ1X7QLRC5K7CY9GE11
Y
N
JPMorgan Chase Bank, N.A.
7H6GLXDRUGQFU57RNE97
N
Y
N
NYLIFE Securities LLC
8-15517
000005167
00000000000000000000
0.00000000
NYLIFE Distributors LLC
8-46655
000035350
00000000000000000000
0.00000000
Morgan Stanley & Co. LLC
8-15869
000008209
9R7GPTSO7KV3UQJZQ078
64565.40000000
Wells Fargo Securities, LLC
8-65876
000126292
VYVVCKR63DVZZN70PB21
24946.16000000
Barclays Capital, Inc.
8-41342
000019714
AC28XWWI3WIBK2824319
31056.28000000
RBC Capital Markets, LLC
8-45411
000031194
549300LCO2FLSSVFFR64
26793.28000000
Goldman Sachs & Co. LLC
8-00129
000000361
FOR8UP27PHTHYVLBNG30
295901.60000000
UBS Securities LLC
8-22651
000007654
T6FIZBDPKLYJKFCRVK44
30733.76000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
57793.18000000
BofA Securities, Inc.
8-69787
000283942
549300HN4UKV1E2R3U73
102964.28000000
National Financial Services LLC
8-26740
000013041
549300JRHF1MHHWUAW04
123708.33000000
Citigroup Global Markets Inc.
8-08177
000007059
MBNUM2BPBDO7JBLYG310
21968.40000000
899516.07000000
Citigroup Global Markets Inc.
8-08177
000007059
MBNUM2BPBDO7JBLYG310
9412933.55000000
J.P. Morgan Securities LLC
8-35008
000000079
ZBUT11V806EZRVTWT807
343088227.88999999
352501161.44000000
Y
702321081.00000000
Uncommitted
100000000.00000000
N
Committed
600000000.00000000
N
N
N
N
false
false
true
false
false
false
INTERNAL CONTROL RPT
2
MainStay_Funds_Trust_NCEN.txt
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Report of Independent Registered Public Accounting Firm
To the Shareholders of the Fund and Board of Trustees
MainStay Funds Trust:
In planning and performing our audit of the financial statements of MainStay
Cushing MLP Premier Fund (the Fund), one of the funds comprising MainStay
Funds Trust, as of and for the year ended November 30, 2022, in accordance
with the standards of the Public Company Accounting Oversight Board (United
States), we considered the Fund's internal control over financial reporting,
including controls over safeguarding securities, as a basis for designing our
auditing procedures for the purpose of expressing our opinion on the financial
statements and to comply with the requirements of Form N-CEN, but not for the
purpose of expressing an opinion on the effectiveness of the Fund's internal
control over financial reporting. Accordingly, we express no such opinion.
Management of the Fund is responsible for establishing and maintaining
effective internal control over financial reporting. In fulfilling this
responsibility, estimates and judgments by management are required to assess
the expected benefits and related costs of controls. A company's internal
control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation
of financial statements for external purposes in accordance with generally
accepted accounting principles. A company's internal control over financial
reporting includes those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company;
(2) provide reasonable assurance that transactions are recorded as necessary
to permit preparation of financial statements in accordance with generally
accepted accounting principles, and that receipts and expenditures of the
company are being made only in accordance with authorizations of management
and directors of the company; and (3) provide reasonable assurance regarding
prevention or timely detection of unauthorized acquisition, use, or
disposition of the company's assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation
of effectiveness to future periods are subject to the risk that controls may
become inadequate because of changes in conditions, or that the degree of
compliance with the policies or procedures may deteriorate.
A deficiency in internal control over financial reporting exists when the
design or operation of a control does not allow management or employees, in
the normal course of performing their assigned functions, to prevent or detect
misstatements on a timely basis. A material weakness is a deficiency, or a
combination of deficiencies, in internal control over financial reporting,
such that there is a reasonable possibility that a material misstatement of
the company's annual or interim financial statements will not be prevented or
detected on a timely basis.
Our consideration of the Fund's internal control over financial reporting was
for the limited purpose described in the first paragraph and would not
necessarily disclose all deficiencies in internal control that might be
material weaknesses under standards established by the Public Company
Accounting Oversight Board (United States). However, we noted no deficiencies
in the Fund's internal control over financial reporting and its operation,
including controls over safeguarding securities, that we consider to be a
material weakness as defined above as of November 30, 2022.
This report is intended solely for the information and use of the management
and the Board of Trustees of the MainStay Funds Trust, and the Securities and
Exchange Commission and is not intended to be and should not be used by anyone
other than these specified parties.
/s/ KPMG LLP
Philadelphia, Pennsylvania
January 25, 2023